Global Controlled Release Topical Patch Market Research Report 2025

Publication ID:

PB505250111

Publication Date:

May 6, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for Controlled Release Topical Patch was valued at US$ 1301 million in the year 2024 and is projected to reach a revised size of US$ 1862 million by 2031, growing at a CAGR of 5.3% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Controlled Release Topical Patch competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Controlled-release topical patches are topical preparations that slowly release drugs through the skin into the body or local tissues. Controlled-release technology is used to adjust the drug release rate to maintain a stable drug concentration and prolong the duration of action. The patch structure usually includes a drug carrier, a controlled-release layer, and an adhesive layer. It has the advantages of easy use, continuous drug administration, and reduced adverse reactions. It is widely used in analgesia, hormone regulation, cardiovascular treatment, and chronic disease management.
North American market for Controlled Release Topical Patch is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Controlled Release Topical Patch is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Controlled Release Topical Patch include Hisamitsu Pharmaceutical, Novartis, Viatris, Bayer, LTS Lohmann, Noven Pharmaceuticals, ProSolus Pharmaceuticals, Vaxess Technologies, Enable Injections, Henan Lingrui Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Controlled Release Topical Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Controlled Release Topical Patch.
The Controlled Release Topical Patch market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Controlled Release Topical Patch market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Controlled Release Topical Patch manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Hisamitsu Pharmaceutical
Novartis
Viatris
Bayer
LTS Lohmann
Noven Pharmaceuticals
ProSolus Pharmaceuticals
Vaxess Technologies
Enable Injections
Henan Lingrui Pharmaceutical
Luye Pharma
Segment by Type
Diffusion-Controlled Patch
Osmosis-Controlled Patch
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Controlled Release Topical Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Controlled Release Topical Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Controlled Release Topical Patch Market Overview
1.1 Product Definition
1.2 Controlled Release Topical Patch by Type
1.2.1 Global Controlled Release Topical Patch Market Value Comparison by Type (2024 VS 2031)
1.2.2 Diffusion-Controlled Patch
1.2.3 Osmosis-Controlled Patch
1.3 Controlled Release Topical Patch by Application
1.3.1 Global Controlled Release Topical Patch Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Controlled Release Topical Patch Market Size Estimates and Forecasts
1.4.1 Global Controlled Release Topical Patch Revenue 2020-2031
1.4.2 Global Controlled Release Topical Patch Sales 2020-2031
1.4.3 Global Controlled Release Topical Patch Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Controlled Release Topical Patch Market Competition by Manufacturers
2.1 Global Controlled Release Topical Patch Sales Market Share by Manufacturers (2020-2025)
2.2 Global Controlled Release Topical Patch Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Controlled Release Topical Patch Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Controlled Release Topical Patch, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Controlled Release Topical Patch, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Controlled Release Topical Patch, Product Type & Application
2.7 Global Key Manufacturers of Controlled Release Topical Patch, Date of Enter into This Industry
2.8 Global Controlled Release Topical Patch Market Competitive Situation and Trends
2.8.1 Global Controlled Release Topical Patch Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Controlled Release Topical Patch Players Market Share by Revenue
2.8.3 Global Controlled Release Topical Patch Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Controlled Release Topical Patch Market Scenario by Region
3.1 Global Controlled Release Topical Patch Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Controlled Release Topical Patch Sales by Region: 2020-2031
3.2.1 Global Controlled Release Topical Patch Sales by Region: 2020-2025
3.2.2 Global Controlled Release Topical Patch Sales by Region: 2026-2031
3.3 Global Controlled Release Topical Patch Revenue by Region: 2020-2031
3.3.1 Global Controlled Release Topical Patch Revenue by Region: 2020-2025
3.3.2 Global Controlled Release Topical Patch Revenue by Region: 2026-2031
3.4 North America Controlled Release Topical Patch Market Facts & Figures by Country
3.4.1 North America Controlled Release Topical Patch Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Controlled Release Topical Patch Sales by Country (2020-2031)
3.4.3 North America Controlled Release Topical Patch Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Controlled Release Topical Patch Market Facts & Figures by Country
3.5.1 Europe Controlled Release Topical Patch Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Controlled Release Topical Patch Sales by Country (2020-2031)
3.5.3 Europe Controlled Release Topical Patch Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Controlled Release Topical Patch Market Facts & Figures by Region
3.6.1 Asia Pacific Controlled Release Topical Patch Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Controlled Release Topical Patch Sales by Region (2020-2031)
3.6.3 Asia Pacific Controlled Release Topical Patch Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Controlled Release Topical Patch Market Facts & Figures by Country
3.7.1 Latin America Controlled Release Topical Patch Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Controlled Release Topical Patch Sales by Country (2020-2031)
3.7.3 Latin America Controlled Release Topical Patch Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Controlled Release Topical Patch Market Facts & Figures by Country
3.8.1 Middle East and Africa Controlled Release Topical Patch Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Controlled Release Topical Patch Sales by Country (2020-2031)
3.8.3 Middle East and Africa Controlled Release Topical Patch Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Controlled Release Topical Patch Sales by Type (2020-2031)
4.1.1 Global Controlled Release Topical Patch Sales by Type (2020-2025)
4.1.2 Global Controlled Release Topical Patch Sales by Type (2026-2031)
4.1.3 Global Controlled Release Topical Patch Sales Market Share by Type (2020-2031)
4.2 Global Controlled Release Topical Patch Revenue by Type (2020-2031)
4.2.1 Global Controlled Release Topical Patch Revenue by Type (2020-2025)
4.2.2 Global Controlled Release Topical Patch Revenue by Type (2026-2031)
4.2.3 Global Controlled Release Topical Patch Revenue Market Share by Type (2020-2031)
4.3 Global Controlled Release Topical Patch Price by Type (2020-2031)
5 Segment by Application
5.1 Global Controlled Release Topical Patch Sales by Application (2020-2031)
5.1.1 Global Controlled Release Topical Patch Sales by Application (2020-2025)
5.1.2 Global Controlled Release Topical Patch Sales by Application (2026-2031)
5.1.3 Global Controlled Release Topical Patch Sales Market Share by Application (2020-2031)
5.2 Global Controlled Release Topical Patch Revenue by Application (2020-2031)
5.2.1 Global Controlled Release Topical Patch Revenue by Application (2020-2025)
5.2.2 Global Controlled Release Topical Patch Revenue by Application (2026-2031)
5.2.3 Global Controlled Release Topical Patch Revenue Market Share by Application (2020-2031)
5.3 Global Controlled Release Topical Patch Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Hisamitsu Pharmaceutical
6.1.1 Hisamitsu Pharmaceutical Company Information
6.1.2 Hisamitsu Pharmaceutical Description and Business Overview
6.1.3 Hisamitsu Pharmaceutical Controlled Release Topical Patch Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Hisamitsu Pharmaceutical Controlled Release Topical Patch Product Portfolio
6.1.5 Hisamitsu Pharmaceutical Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Company Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Controlled Release Topical Patch Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Novartis Controlled Release Topical Patch Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Viatris
6.3.1 Viatris Company Information
6.3.2 Viatris Description and Business Overview
6.3.3 Viatris Controlled Release Topical Patch Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Viatris Controlled Release Topical Patch Product Portfolio
6.3.5 Viatris Recent Developments/Updates
6.4 Bayer
6.4.1 Bayer Company Information
6.4.2 Bayer Description and Business Overview
6.4.3 Bayer Controlled Release Topical Patch Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Bayer Controlled Release Topical Patch Product Portfolio
6.4.5 Bayer Recent Developments/Updates
6.5 LTS Lohmann
6.5.1 LTS Lohmann Company Information
6.5.2 LTS Lohmann Description and Business Overview
6.5.3 LTS Lohmann Controlled Release Topical Patch Sales, Revenue and Gross Margin (2020-2025)
6.5.4 LTS Lohmann Controlled Release Topical Patch Product Portfolio
6.5.5 LTS Lohmann Recent Developments/Updates
6.6 Noven Pharmaceuticals
6.6.1 Noven Pharmaceuticals Company Information
6.6.2 Noven Pharmaceuticals Description and Business Overview
6.6.3 Noven Pharmaceuticals Controlled Release Topical Patch Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Noven Pharmaceuticals Controlled Release Topical Patch Product Portfolio
6.6.5 Noven Pharmaceuticals Recent Developments/Updates
6.7 ProSolus Pharmaceuticals
6.7.1 ProSolus Pharmaceuticals Company Information
6.7.2 ProSolus Pharmaceuticals Description and Business Overview
6.7.3 ProSolus Pharmaceuticals Controlled Release Topical Patch Sales, Revenue and Gross Margin (2020-2025)
6.7.4 ProSolus Pharmaceuticals Controlled Release Topical Patch Product Portfolio
6.7.5 ProSolus Pharmaceuticals Recent Developments/Updates
6.8 Vaxess Technologies
6.8.1 Vaxess Technologies Company Information
6.8.2 Vaxess Technologies Description and Business Overview
6.8.3 Vaxess Technologies Controlled Release Topical Patch Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Vaxess Technologies Controlled Release Topical Patch Product Portfolio
6.8.5 Vaxess Technologies Recent Developments/Updates
6.9 Enable Injections
6.9.1 Enable Injections Company Information
6.9.2 Enable Injections Description and Business Overview
6.9.3 Enable Injections Controlled Release Topical Patch Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Enable Injections Controlled Release Topical Patch Product Portfolio
6.9.5 Enable Injections Recent Developments/Updates
6.10 Henan Lingrui Pharmaceutical
6.10.1 Henan Lingrui Pharmaceutical Company Information
6.10.2 Henan Lingrui Pharmaceutical Description and Business Overview
6.10.3 Henan Lingrui Pharmaceutical Controlled Release Topical Patch Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Henan Lingrui Pharmaceutical Controlled Release Topical Patch Product Portfolio
6.10.5 Henan Lingrui Pharmaceutical Recent Developments/Updates
6.11 Luye Pharma
6.11.1 Luye Pharma Company Information
6.11.2 Luye Pharma Description and Business Overview
6.11.3 Luye Pharma Controlled Release Topical Patch Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Luye Pharma Controlled Release Topical Patch Product Portfolio
6.11.5 Luye Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Controlled Release Topical Patch Industry Chain Analysis
7.2 Controlled Release Topical Patch Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Controlled Release Topical Patch Production Mode & Process Analysis
7.4 Controlled Release Topical Patch Sales and Marketing
7.4.1 Controlled Release Topical Patch Sales Channels
7.4.2 Controlled Release Topical Patch Distributors
7.5 Controlled Release Topical Patch Customer Analysis
8 Controlled Release Topical Patch Market Dynamics
8.1 Controlled Release Topical Patch Industry Trends
8.2 Controlled Release Topical Patch Market Drivers
8.3 Controlled Release Topical Patch Market Challenges
8.4 Controlled Release Topical Patch Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Hisamitsu Pharmaceutical
Novartis
Viatris
Bayer
LTS Lohmann
Noven Pharmaceuticals
ProSolus Pharmaceuticals
Vaxess Technologies
Enable Injections
Henan Lingrui Pharmaceutical
Luye Pharma

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂